NASDAQ:ENSC | Cash Flow Statement | Ensysce Biosciences, Inc.

Complete source-backed cash-flow history.

Available history
2018-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$2.57M
2026-03-31-$3.56M-$3.5M-$63,947.00
2025-12-31-$2.77M-$1.53M$0.00$0.00$4.16M
2025-09-30-$3.73M
2025-06-30-$1.73M
2025-03-31-$1.95M-$1.71M$1.26M
2024-12-31-$3.56M-$764,090.00$112,575.00
2024-09-30$661,769.00
2024-06-30-$1.97M
2024-03-31-$3.12M-$3.41M$5.69M
2023-12-31-$3.5M-$1.8M$1.46M
2023-09-30-$2.69M
2023-06-30-$2.24M
2023-03-31-$2.19M-$3.61M$1.87M
2022-12-31-$5.48M-$3.3M$0.00$1.94M
2022-09-30-$9.86M
2022-06-30-$7.92M
2022-03-31-$950,925.00-$3.44M$4,500.00-$391,270.00
2021-12-31-$10.1M-$3.77M$9.19M
2021-09-30-$17.16M
2021-06-30-$935,544.00
2021-03-31-$1.71M-$517,149.00-$62,500.00$612,862.00
2020-12-31$2.56M-$533,857.00$183.41M$0.00
2020-09-30$1.57M
2020-06-30-$704,498.00
2020-03-31$1.79M-$234,388.00$134.62M$136.28M-$135.28M
2019-12-31-$1.32M-$425,756.00$11.23M-$11.02M
2019-09-30$489,723.00
2019-06-30$418,902.00
2019-03-31$775,913.00-$294,366.00$151,204.00-$8,640.00
2018-12-31$723,208.00-$458,641.00$362,773.00$0.00
2018-09-30$577,649.00
2018-06-30$415,110.00
2018-03-31$406,066.00-$216,827.00$61,420.00-$32,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$10.18M-$7.81M$123,643.00-$123,643.00$8.74M
2024-12-31-$7.99M-$7.5M$9.88M
2023-12-31-$10.63M-$10.78M$8.76M
2022-12-31-$24.21M-$17.89M$4,500.00$8.77M
2021-12-31-$29.15M-$8.24M$20.31M
2020-12-31$2.4M-$1.25M$183.4M$1.1M
2019-12-31$365,954.00-$1.42M$11.85M$11.58M-$11.03M
2018-12-31$2.12M-$1.24M$838,587.00-$32,000.00